For decades, hormone replacement therapies carried warnings that they increased the risk of cancer and dementia. Now, that ...

In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, no cause and no hope. As an infectious ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of ...

Florida Congressman Vern Buchanan (R) announced a new bipartisan bill called the ASAP Act, which ensures that seniors have ...

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

A new study from the University of Exeter has found that three existing medications could be repurposed to help treat or even ...

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

Company gains NIH Fast-Track award supporting long-term dosing in Alzheimer's patients for planned Phase 1b studies to evaluate OLX-07010, a small molecule inhibitor of tau protein self-association-- ...

A neuropsychologist who researches Alzheimer’s disease at the Icahn School of Medicine at Mount Sinai shares the warning signs she'd look for in her own life.

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...